Here are three reasons why there are better opportunities than INCY and a stock we'd rather own. Founded in 1991 and evolving from a genomics research firm to a commercial-stage drug developer ...

In trading on Tuesday, shares of Incyte Corporation (Symbol: INCY) entered into oversold territory, hitting an RSI reading of 27.5, after changing hands as low as $58.16 per share. By comparison ...

Bank of America Securities analyst Tazeen Ahmad maintained a Buy rating on Incyte (INCY – Research Report) today and set a price target of $87.00. The company’s shares closed yesterday at $57.73.

Even though the stock has become cheaper, we don't have much confidence in Incyte. Here are three reasons why there are better opportunities than INCY and a stock we'd rather own. Founded in 1991 and ...

However, it was also intended to honor his roots as a Sentai soldier superhero. The original Japanese Spider-Man show, which ran for 41 episodes in 1978-1979, made use of the classic costume and ...

Joe Rogan was astonished when he saw a photo of Japanese spider crabs on his podcast. Rogan, who has spoken to guests about wildlife numerous times, was taken aback by the size of the crab.

Shares of NASDAQ INCY opened at $62.08 on Monday. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.97 and a quick ratio of 1.94. The company has a market cap of $12.01 billion ...

Shares of Incyte stock opened at $60.60 on Friday. The company has a 50-day simple moving average of $69.53 and a two-hundred day simple moving average of $70.04. Incyte has a 52-week low of $50. ...